Stay updated on Immunotherapy With BCMA CAR-T Cells in BCMA+ Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy With BCMA CAR-T Cells in BCMA+ Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy With BCMA CAR-T Cells in BCMA+ Multiple Myeloma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The record presents details of a completed Phase I study of BCMA CAR-T immunotherapy for relapsed or refractory multiple myeloma, including its design, eligibility criteria, and outcome measures. It also includes study history, a related publication, and a study protocol document.
    Difference
    96%
    Check dated 2026-11-07T13:00:10.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0 while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:37:31.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The study record itself remains unavailable behind a 403 error.
    Difference
    1%
    Check dated 2026-10-24T17:57:07.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T19:15:33.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T19:49:05.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content. This indicates the record is currently inaccessible.
    Difference
    25%
    Check dated 2026-09-19T20:25:54.000Z thumbnail image

Stay in the know with updates to Immunotherapy With BCMA CAR-T Cells in BCMA+ Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy With BCMA CAR-T Cells in BCMA+ Multiple Myeloma Clinical Trial page.